Hanwha Solutions (009830) Analysis: Solar & Chemical Simultaneous Turnaround, and the KRW 1.81 Trillion Rights Offering Wildcard
Hanwha Solutions (009830) is an integrated chemicals and renewable energy company operating three segments — Chemicals, Solar (Q Cells), and Advanced Materials — and achieved simultaneous profitability across all business segments in Q1 2026. At the same time, the record date for its KRW 1,814.4 billion rights offering was changed to 'TBD' following a correction request from the FSS, leaving the company in a phase where improved earnings and financial uncertainty coexist.
1. Industry Growth Vision — Structural Shifts and Direction
U.S. de-China solar policy is creating a structural price premium environment for module manufacturers that satisfy Non-FEOC (non-Chinese-origin) requirements. Final AD/CVD (anti-dumping and countervailing duties) rulings on modules from four Southeast Asian countries are scheduled for July 2026; once confirmed, competitive volumes from those markets would face structural barriers to U.S. entry. U.S. module manufacturing capacity exceeded 60 GW at end-2025, but actual utilization remains below 50%, and upstream capacity (ingot, wafer, cell) would still fall short of U.S. demand by more than 10 GW even if all announced expansions are fully realized. In the chemicals segment, Middle Eastern chemical facilities — including the Sadara plant — were shut down amid the fallout from the Iran conflict, tightening ethylene and TDI supply, and ethylene spreads have shown a modest recovery.
📌 U.S. upstream cell capacity: a structural scarcity of more than 10 GW below U.S. demand even if all planned expansions are completed
2. Corporate Strategic Position
Hanwha Solutions is the only domestic company with a vertically integrated U.S. solar value chain spanning ingots, wafers, cells, and modules. It operates the Dalton facility (5.3 GW modules) and the Cartersville facility (3.3 GW ingots, wafers, cells, and modules) in the U.S., with cell mass production at Cartersville targeted for Q3 2026 while testing proceeds through April–June*4. Total capacity stands at 8.5 GW modules and 7.3 GW cells. Modules satisfying Non-FEOC and DCA (Domestic Content Adder) requirements structurally command a price premium over Chinese and Southeast Asian products. In the chemicals segment, the introduction of direct power purchase agreements generated cost savings of KRW 27 billion in Q1 alone, and the company proactively procured 60,000 tonnes of Chinese ethylene in April–May to offset raw material shortfalls from declining YNCC utilization.
| Category | Details |
|---|---|
| Competitive Advantage | Only company with vertical integration across the U.S. solar value chain; price premium secured on Non-FEOC- and DCA-compliant modules |
| Market Position | U.S. shipment share above 80%; total capacity of 8.5 GW modules and 7.3 GW cells |
| Strategic Weakness | Debt-to-equity ratio of 196.3%; financial restructuring path unclear amid unconfirmed rights offering schedule |
3. Key Growth Drivers
Solar segment module shipments in Q1 2026 reached 1.9 GW, up 80% quarter-on-quarter, with ASP rising 14% over the prior quarter. AMPC (Advanced Manufacturing Production Credit) expanded to KRW 216.1 billion, driving overall earnings improvement. Once the Cartersville plant commences cell mass production in Q3, it will enable DCA-compliant module output, potentially further widening the price premium4. Hana Securities estimates full-year 2026 operating profit at KRW 762.7 billion1, while Eugene Investment & Securities estimates KRW 927.0 billion3. The chemicals segment exports 90% of its annual TDI production of 150,000 tonnes, and the benefit from the Sadara plant shutdown in the Middle East has been reflected in 2026 results. The company's 2026 module shipment guidance of 9 GW remains unchanged5.
4. Financial & Valuation Summary
At the current price of KRW 43,000 (as of 2026-05-12), Forward PER stands at 16.0x, a premium to the sector average Forward PER of 8.8x. PBR is 0.81x, ROE is -5.5% (still negative), and the debt-to-equity ratio is 196.3%. Full-year 2025 operating margin was -2.7%, but Q1 2026 turned positive at 2.4%. Completion of the rights offering, which would allow repayment of KRW 906.7 billion in debt, remains a prerequisite for meaningful balance sheet improvement.
📌 Forward PER of 16.0x represents a premium to the sector average (8.8x); sustained earnings turnaround is the key to justifying this premium
| Metric | Current | Sector Average | Interpretation |
|---|---|---|---|
| Forward PER | 16.0x | 8.8x | Trading at a premium to the sector |
| PBR | 0.81x | — | Trading below book value |
| ROE | -5.5% | — | Still in negative territory |
| Debt-to-Equity | 196.3% | — | Room for improvement contingent on rights offering completion |
5. Risks and Monitoring Points
The KRW 1,814.4 billion rights offering record date has been changed to 'TBD' following a second FSS correction request, and the risk of delayed debt repayment and a potential credit rating downgrade coexist. YNCC ethylene utilization has dropped to approximately 50% since March, leaving raw material procurement in the chemicals segment as a near-term vulnerability. Changes to U.S. IRA policy are also directly tied to the sustainability of AMPC benefits.
- ⚠️ Further delay or withdrawal of the rights offering would impair the ability to repay KRW 906.7 billion in debt and risk a credit rating downgrade
- ⚠️ AD/CVD final ruling uncertainty — risk of delayed restructuring of Southeast Asian re-routed volumes in the market
- ⚠️ Prolonged YNCC ethylene utilization at the 50% level would push up chemicals input costs
- ⚠️ Risk of reduced AMPC benefits from changes to U.S. renewable energy policy, including IRA amendments
- 📌 Monthly module ASP trend: whether Q2 2026 shows further upside vs. Q1 2026 (cumulative +5 cent/W potential)
- 📌 Re-announcement of rights offering schedule and FSS approval status
- 📌 YNCC ethylene utilization recovery trajectory (whether the 65% target for May–June is met)
- 📌 AD/CVD final ruling outcome (July 2026)
6. Changes Since Prior Analysis
Initial coverage — no prior report exists. This report is the first analysis of Hanwha Solutions (009830), prepared following the Q1 2026 earnings release and the disclosure of the corrected rights offering schedule.
Hanwha Solutions achieved all-segment profitability in Q1 2026 through vertical integration of its U.S. solar value chain and proactive raw material procurement in the chemicals segment; however, a debt-to-equity ratio of 196.3% and uncertainty around the rights offering schedule remain financial variables that warrant close monitoring. This report is for informational purposes only and does not constitute investment advice.
📎 출처 및 추정 근거
- 1 2026F full-year operating profit of KRW 762.7 billion — Hana Securities Earnings Review (2026-04-29), based on assumptions of 9 GW shipments, USD/KRW 1,450, and module ASP +5 cent/W for 2026
- 2 Q2 2026 AMPC estimate of KRW 213.6 billion — Hana Securities report (2026-04-29), based on company guidance that Q2 2026 shipment volume will be broadly in line with Q1 2026
- 3 2026E full-year operating profit of KRW 927.0 billion — Eugene Investment & Securities report (2026-04-29), reflecting company guidance of KRW 21 trillion in revenue and KRW 900 billion in operating profit
- 4 Cartersville cell mass production target of Q3 2026 — Hanwha Solutions Q1 2026 earnings conference call Q&A (2026-04-28), confirming that most utility issues have been resolved and testing is ongoing through April–June; corroborated by Eugene Investment & Securities report (2026-04-29)
- *5 2026 shipment guidance of 9 GW — Hanwha Solutions Q1 2026 earnings conference call (2026-04-28), company announced maintenance of official guidance
본 보고서는 정보 제공 목적이며 투자 권유가 아닙니다. 투자 결정은 본인 책임입니다.
댓글 없음:
댓글 쓰기